192 related articles for article (PubMed ID: 14634919)
1. [Plasmapheresis: its use in multiple sclerosis and other demyelinating processes of the central nervous system. An observation study].
Meca-Lallana JE; Rodríguez-Hilario H; Martínez-Vidal S; Saura-Luján I; Carretón-Ballester A; Escribano-Soriano JB; Martín-Fernández J; Genovés-Aleixandre A; Mateo-Bosch E; Fernández-Barreiro A
Rev Neurol; 2003 Nov 16-30; 37(10):917-26. PubMed ID: 14634919
[TBL] [Abstract][Full Text] [Related]
2. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.
Mikaeloff Y; Suissa S; Vallée L; Lubetzki C; Ponsot G; Confavreux C; Tardieu M;
J Pediatr; 2004 Feb; 144(2):246-52. PubMed ID: 14760270
[TBL] [Abstract][Full Text] [Related]
3. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
Ozakbas S; Ormeci B; Idiman E
J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
Llufriu S; Castillo J; Blanco Y; Ramió-Torrentà L; Río J; Vallès M; Lozano M; Castellà MD; Calabia J; Horga A; Graus F; Montalban X; Saiz A
Neurology; 2009 Sep; 73(12):949-53. PubMed ID: 19770470
[TBL] [Abstract][Full Text] [Related]
6. A case report of plasmapheresis in the treatment of acute disseminated encephalomyelitis.
Shinozaki K; Oda S; Sadahiro T; Nakamura M; Abe R; Nakamura S; Hattori N; Hirano S; Hattori T; Hirasawa H
Ther Apher Dial; 2008 Oct; 12(5):401-5. PubMed ID: 18937725
[TBL] [Abstract][Full Text] [Related]
7. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange combined with immunomodulating agents in secondary progressive multiple sclerosis patients.
Grapsa E; Triantafyllou N; Rombos A; Lagouranis A; Dimopoulos MA
Ther Apher Dial; 2008 Apr; 12(2):105-8. PubMed ID: 18387157
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
[TBL] [Abstract][Full Text] [Related]
10. [Acute disseminated encephalomyelitis: study of factors involved in a possible development towards multiple sclerosis].
Tur C; Téllez N; Rovira A; Tintoré M; Río J; Nos C; Perkal H; Castilló J; Horga A; León A; Galán I; Sastre-Garriga J; Montalbán X
Neurologia; 2008 Nov; 23(9):546-54. PubMed ID: 18802800
[TBL] [Abstract][Full Text] [Related]
11. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
Ozakbas S; Cagiran I; Ormeci B; Idiman E
J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
[TBL] [Abstract][Full Text] [Related]
12. A closer look at plasmapheresis in multiple sclerosis: the cons.
Tindall R
Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: interferon beta for some serious forms.
Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
[TBL] [Abstract][Full Text] [Related]
15. [Plasmapheresis in multiple sclerosis].
Fuchs S; Pogglitsch H; Ladurner G; Lechner H
Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
[TBL] [Abstract][Full Text] [Related]
16. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
17. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study.
Meca-Lallana JE; Hernández-Clares R; León-Hernández A; Genovés Aleixandre A; Cacho Pérez M; Martín-Fernández JJ
Clin Ther; 2013 Apr; 35(4):474-85. PubMed ID: 23541130
[TBL] [Abstract][Full Text] [Related]
19. [Multiple sclerosis in children: clarifying its place among the demyelinating spectrum].
Peña JA; Montiel-Nava C; Ravelo ME; González S; Mora La-Cruz E
Invest Clin; 2006 Dec; 47(4):413-25. PubMed ID: 17176909
[TBL] [Abstract][Full Text] [Related]
20. [De Seze et al. criteria: application to a series of 14 patients presenting a first severe acute demyelinating event].
Bozzolo E; Bourg V; Chanalet S; Lebrun C
Rev Neurol (Paris); 2009 Jan; 165(1):38-47. PubMed ID: 18835615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
